• 제목/요약/키워드: Polymerization rate

검색결과 362건 처리시간 0.019초

이종 이식된 구강편평세포 암종에서 Paclitaxel ($Taxol^{(R)}$)의 항암 효과 (THE ANTICANCER EFFECT OF PACLITAXEL($Taxol^{(R)}$) IN ORAL SQUAMOUS CELL CARCINOMA XENOGRAFT)

  • 김기환;김철환;한세진;이재훈
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제28권2호
    • /
    • pp.95-110
    • /
    • 2006
  • The treatment for oral and maxillofacial carcinoma with chemotherapeutic agents is evaluated by many effective methods to reduce the tumor mass and cancer cell proliferation. However these chemotherapy have many serious side effects, such as bone marrow suppression, renal toxicity, G-I troubles. Therefore a possible approach to develop a clinically applicable chemotherapeutic agent is to screen anticancer activity of Taxol which is known to have very little side effect and have been used to breast cancer and ovarian carcinoma. Taxol is a new anti-microtubular anti-cancer agent extracted from the bark of the Pacific yew, Taxus brevifolia. Paclitaxel(Taxol) acts by promoting tubulin polymerization and over stabilizing microtubules agianst depolymerization. Despite the constant improvements of methods of the cancer treatment especially chemotherapy, the rate of cancer metastasis and recurrent are not decreased. Thus the investigation of new drug which have very little side effect and a possible clinically application continues to be a high priority. Considering that the Taxol have shown very effective chemotherapeutic agent with relatively low toxicity in many solid tumors, it deserves to evaluate its efficacy in oral squamous cell carcinoma. In this study, to investigate the in-vivo and in-vitro anti-cancer efficacy of Taxol in oral squamous cell carcinoma and lastly, the potency of Paclitaxel in the clinical application for oral cancer was evaluated. In vivo study, after HN22 cell line were xenografted in nude mice, the growth of tumor mass was observed, 3 mg/Kg taxol was injected intraperitoneally into nude mice containing tumor mass. The methods of these study were measurement of total volume of tumor mass, histopathologic study, immunohistochemical study, drug resistance assay, growth curve, MTT assay, flow cytometry, cDNA microarray in vivo and in vitro. The results were obtained as following. 1. The visual inspection of the experimental group showed that the volume of the tumor mass was slightly decreased but no significant difference with control group. 2. Ki-67 index was decreased at weeks 4 in experimental group. 3. Microscopic view of the xenografted tumor mass showed well differentiated squamous cell carcinoma and after Taxol injection, some necrotic tissue was seen weeks 4. 4. The growth curve of the tumor cells were decreased after 1day Taxol treatment. 5. According to the MTT assay, HN22 cell line showed relative drug resistancy above $5\;{\mu}g/ml$ concentrations of Taxol. 6. In drug resistance assay, the decrease of cell counts was seen relatively according to concentration. 7. In Flow cytometry, G2M phase cell arrests were seen in low concentration of the Taxol, while S phase cell arrests were seen in high concentration of the Taxol. 8. Using cDNA microarray technique, variable gene expression of ANGPTL4, TXNRD1, FAS, RRAGA, CTGF, CYCLINEA, P19, DUSP5, CEBPG, BTG1 were detacted in the oral squamous cell carcinoma cell after taxol treatment. In this study paclitaxel is effective against oral squamous cell carcinoma cell lines in vitro, but week effect was observed in vivo. So we need continuous study about anticancer effect of taxol in vivo in oral squamous cell carcinoma.

Heterotrimeric Kinesin 2 모터 단백질의 Carboxyl-말단과 β2-tubulin의 결합 (The Carboxyl-terminal Tail of a Heterotrimeric Kinesin 2 Motor Subunit Directly Binds to β2-tubulin)

  • 정영주;박성우;김상진;이원희;김무성;엄상화;석대현
    • 생명과학회지
    • /
    • 제29권3호
    • /
    • pp.369-375
    • /
    • 2019
  • 미세소관은 알파- 와 베타-tubulin의 이량체가 종합되어 형성되며, 또한 세포내에서 tubulin 수송은 섬모나 편모와 같은 세포 부착 기관의 성장에 중요한 역할을 한다. Kinesin 2는 kinesin superfamily (KIF)의 분자 모터 단백질의 한 종류로 미세소관를 따라 다양한 운반체를 운반하며, 2종류의 다른 모터 단백질(KIF3A, KIF3B)과 kinesin-associated protein 3 (KAP3)로 구성되어 있다. Kinesin 2는 KIF3A의 cargo binding domain을 통하여 다양한 단백질과의 결합이 알려져 있지만, 아직 결합단백질의 다수는 아직 밝혀지지 않았다. 본 연구에서 KIF3A와 결합하는 단백질을 분리하기 위하여 효모 two-hybrid system을 사용하여 탐색한 결과 미세소관의 단위체의 한 종류인 ${\beta}2-tubulin$ type (Tubb2)을 분리하였다. Tubb2는 KIF3A와 결합하지만, KIF3B, KIF5B와 kinesin light chain 1 (KLC1)과는 결합하지 않았다. Tubb2의 C-말단은 KIF3A와의 결합에 필요하며, 다른 KIF3A는 Tubb의 isoforms인 Tubb1, Tubb2, Tubb3, Tubb4, Tubb5와도 결합하였다. 그러나 Tuba1은 KIF3A와 결합하지 않았다. 생쥐의 뇌 파쇄액을 KIF3A 항체로 면역침강한 결과 Tubb2는 heterotrimeric kinesin 2의 구성단백질들과 같이 침강하였다. 이러한 결과들은 heterotrimeric kinesin 2는 tubulin과 결합하여 세포 내에서 tubulins을 운반하는 것을 시사한다.